Skip to main content


Health

During a phase one clinical trial of a new treatment for MS patients, researchers were able to curtail the body's attacks on myelin by 50 to 75 percent, while sustaining the functionality of the rest of the immune system.
347 of 1555



Newsletter Sign Up

Daily Readings

Reading 1, Job 9:1-12, 14-16
Job spoke next. He said: Indeed, I know it is as you say: how ... Read More

Psalm, Psalms 88:10-11, 12-13, 14-15
Do you work wonders for the dead, can shadows rise up to praise ... Read More

Gospel, Luke 9:57-62
As they travelled along they met a man on the road who said to ... Read More

Saint of the Day

October 1 Saint of the Day

St. Therese of Lisieux
October 1: Generations of Catholics have admired this young saint, called ... Read More